Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with SIB-IMRT for NSCLC Brain Metastases
NCT03732482Phase 3Unknown
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Mar 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of temozolomide in non-small cell lung cancer (NSCLC), sponsored by Taizhou Hospital of Zhejiang Province. Status: unknown.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03732482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732482.